Target intelligence / Profile preview

Ribosomal oxygenase 1 (RIOX1)

Target
RIOX1
Molecular classification
Enzyme, Histone modification, Oxygenase, Lysine-specific demethylase, Dioxygenase
01

Overview

Ribosomal oxygenase 1 (RIOX1) is a nucleolar enzyme best known for its roles as a histone lysine demethylase and as a ribosomal protein histidine hydroxylase. It specifically demethylates lysines on histone H3, particularly H3K4me3 and H3K4me1, with weaker activity on H3K36me2, thus playing a role in epigenetic regulation of gene expression. In addition to chromatin targets, RIOX1 hydroxylates histidine residues in ribosomal protein L8, implicating it in ribosome biogenesis. RIOX1 also demethylates non-histone proteins, such as cyclic GMP-AMP synthase (cGAS), and regulates DNA repair pathways, particularly by modulating homologous recombination after ionizing radiation via cGAS demethylation. It participates in MYC-induced transcriptional activation and is involved in the regulation of osteoblast differentiation. RIOX1 is associated with several disease contexts, including cancer (notably lung cancer) and Sotos syndrome 3. It is broadly considered a potential therapeutic enzyme target due to its central role in chromatin and DNA-damage response pathways.

Other names
Ribosomal oxygenase 1RIOX1NO66MAPJDJMJD9C14orf169Myc-associated protein with JmjC domainNucleolar protein 66Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66Ribosomal oxygenase NO6660S ribosomal protein L8 histidine hydroxylasehsNO66ROXURLC2
02

Mechanism of action

Lysine demethylation on histones (e.g., H3K4me3, H3K36me2); Histidine hydroxylation of ribosomal proteins; Demethylation of non-histone proteins such as cyclic GMP-AMP synthase (cGAS); Regulation of homologous recombination (HR) DNA repair

03

Biological functions

Protein demethylationPeptidyl-histidine dioxygenase activityNegative regulation of DNA-templated transcriptionNegative regulation of osteoblast differentiationRegulation of ribosome biogenesisDemethylation of non-histone proteinsRegulation of DNA double-strand break repair via homologous recombination (HR)
04

Disease associations

CancerLung cancerSotos syndrome 3Cellular response to DNA damage
05

Safety considerations

Potential challenge in targeting due to its dual roles in histone and non-histone protein modification, with possible effects on genome maintenance and normal cell viability.
06

Biomarkers

High expression may serve as a marker for radiosensitivity or DNA repair efficiency in certain cells and cancersReported as \"up-regulated in lung cancer\"

Beyond the preview

Go deeper on Ribosomal oxygenase 1 (RIOX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal oxygenase 1 (RIOX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call